In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 28 for your search:
Drug:  imiquimod
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: HSC-MS-06-0478, OSP-24412, NCT00581425

2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 45 and over
Sponsor: Other
Protocol IDs: LIMIT-1, NCT01161888

3.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: GW01-1001, NCT01413763

4.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: X-03016-3284, 2010-022054-16, NCT01453179

5.

Phase: Phase III, Phase II
Type: Prevention, Treatment
Status: Enrolling by invitation
Age: 18 and over
Sponsor: Other
Protocol IDs: C.2005.087, NCT00384124

6.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: ITIC1.0, NCT00941252

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: CRUK-LON-SINS-C7484/A2869, EU-20205, NCT00066872

8.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 75090409, NCT01212562

9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SYM 2012-01, NCT01686152

10.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069223, NCCTG-989251, NCI-P02-0208, NCT00031759

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: 060069, 06-C-0069, NCI-06-C-0069, 7676, NCI-7676, NCI-P6703, NCT00304057, NCT00273910

12.

Phase: Phase II
Type: Supportive care
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: Eudract number: 2006-004902-16, LREC number: 06/Q2201/143, NCT00596336

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CYT004-MelQbG10 04, NCT00651703

14.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 07-380, NCT00799110

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 6578, NCI-2010-00040, R01CA138521, 131, UWCC-6578, FHCRC-6578, IR-6578, NCT00821964

16.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: NYU 09-0225, NCT00899574

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: LIMTOP-I, NCT01611480

18.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TMX-101-003, NCT01731652

19.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000355151, NCI-02-CC-0289, 3M-1454-IMIQ, NCT00079300

20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 12 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000430925, UVACC-MEL-45, UVACC-HIC-11490, UVACC-34204, NCT00118313

21.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NYU 04-53, LUD2004-006, NCT00142454

22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 100
Sponsor: Other
Protocol IDs: OU-12576, 12576, OU-ISPI, NCT00453050

23.

Phase: Phase I
Type: Treatment
Status: Completed
Age: Any age
Sponsor: Other
Protocol IDs: 2008LS053, 0809M48641, NCT01171469

24.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: LU 1006 - IDO, NCT01219348

25.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: IMQC 1220, NCT01788007
1   
New Search